UNICEF says number of severely malnourished children doubles in North Darfur, W. Sudan
In a statement, UNICEF reported a 46 percent increase in the number of children receiving treatment for SAM across Sudan's five Darfur states between January and May 2025, compared to the same period in 2024.
"In North Darfur alone, more than 40,000 children were admitted for treatment for SAM in the first five months of the year -- double the number for the same period last year," according to the statement.
"In nine out of 13 localities, the rate of acute malnutrition has surpassed emergency levels set by the World Health Organization," it noted.
"Children in Darfur are being starved by conflict and cut off from the very aid that could save them," Sheldon Yett, UNICEF representative for Sudan, was quoted in the statement as saying.
According to UNICEF, the situation was equally alarming in other parts of the country as SAM admissions rose by more than 70 percent in North Kordofan, by 174 percent in Khartoum State, and by 683 percent in Gezira State.
UNICEF warned that, with Sudan now in the peak of the lean season, the risk of mass child mortality is growing rapidly in areas already near famine thresholds, adding that cholera outbreaks, measles cases, and collapsing health services are compounding the crisis.
Sudan remains gripped by a civil conflict, which erupted in April 2023. The fighting has killed tens of thousands of people and displaced millions, both internally and across borders, deepening the country's humanitarian crisis.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sinar Daily
16 hours ago
- Sinar Daily
'Groundbreaking' drug could slow down progression of type 1 diabetes
LONDON - A 'groundbreaking' drug to slow down the development of type 1 diabetes is being tried by a handful of patients in the UK, reported Xinhua. Teplizumab, which is already approved in the United States (US), trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average of three years. A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS. - 123RF photo With type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas, meaning blood sugar levels are no longer regulated by the body. If blood sugar is too high or too low, it can cause serious health problems and even death. People with type 1, therefore, need daily insulin. Dentist and mother-of-two, Hannah Robinson, from Devon, is the first adult in the UK to try the drug in the hope it can delay the condition. She is having treatment at the Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1. A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS. The 36-year-old said: "For me, this new drug offers more freedom and the chance to focus on my health before I have to start thinking differently and managing life as somebody needing daily insulin. "This isn't just about what I eat or monitoring my glucose, it is also about having more control and not feeling defined by my condition. "This treatment could potentially pave the way for a future cure for type 1 diabetes, which is incredible. I feel very lucky to be part of this." The new drug teplizumab must be given at the earliest stage of the disease to be effective. Dr Nick Thomas, diabetes consultant and academic clinical lecturer at the University of Exeter, said: "This new treatment represents a really exciting shift in how we manage type 1 diabetes. "For the first time, we will be able to provide targeted treatment early enough in the process to alter the underlying immune process, aiming to slow down how quickly people need insulin. "Approximately half of all type 1 diabetes cases develop in adulthood, and Hannah will be the first adult in the UK to receive this treatment. "I hope that in the future, we may be able to stop people with early type 1 diabetes from needing insulin at all." Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes. The hope is that more people could be offered the drug to delay type 1. Dr Lucy Chambers, head of research impact and communications at Diabetes UK, said: "For people in the early stages of type 1 diabetes, teplizumab offers a groundbreaking opportunity to buy them precious extra years insulin-free. "Right now, it's only available in research settings - and while the excitement is real, urgent work is still needed to ensure it reaches everyone who could benefit. "That means securing a UK licence for teplizumab, establishing national screening programmes to identify people with early-stage type 1 diabetes before symptoms appear, and preparing the NHS to deliver this treatment at scale. "Diabetes UK is proud to be at the forefront of these efforts - funding pioneering research and working closely with the NHS towards a future where immunotherapies become the first-line treatment? for tackling the autoimmune attack at the root of type 1 diabetes." Professor Richard Oram, consultant physician at the Royal Devon and professor at the University of Exeter, said: "Excitingly, teplizumab is the first drug with the potential to delay type 1 diabetes, but needs to be given before clinical diagnosis due to high blood glucose. "It is really important to find new and improved approaches for identifying individuals at elevated risk." - BERNAMA-dpa
The Star
a day ago
- The Star
Cambodia records 7,000 dengue fever cases with 15 deaths in H1 2025
PHNOM PENH: Cambodia reported about 7,000 dengue fever cases in the first half of 2025, similar to the number of cases during the same period last year, a health official said on Thursday (July 12). However, the death toll from the disease dropped to 15 during the January-June period this year from 23 in the same period last year, said Huy Rekol, director of the National Center for Parasitology, Entomology and Malaria Control. "All the patients who died so far this year were children," he told Xinhua. "The deaths occurred because the parents or legal guardians had sent their sick children to the hospital late." He said parents or legal guardians should take their sick children to health centers or state hospitals within 48 hours if they suspect their children are infected with the dengue virus. Rekol also appealed to households to fill in puddles around their houses, saying that they are sources of mosquitoes. Dengue fever is a viral disease transmitted through the bite of an Aedes mosquito, which is a day-biting mosquito. The disease causes an acute illness that usually follows symptoms such as headache, high fever of up to 40 degrees Celsius, exhaustion, severe muscle and joint pain, swollen glands, vomiting and rash. In the Southeast Asian country, the peak of the dengue epidemic period is in the rainy season from May to October. The Ministry of Health on Thursday reminded people to be extra vigilant over dengue fever, saying that the disease has been on the rise since late April and may continue to surge due to increased rainfall. - Xinhua
The Star
2 days ago
- The Star
UNICEF says number of severely malnourished children doubles in North Darfur, W. Sudan
KHARTOUM, July 11 (Xinhua) -- The United Nations Children's Fund (UNICEF) said Friday that the number of children suffering from severe acute malnutrition (SAM) in Sudan's North Darfur region has doubled as a result of the country's ongoing military conflict. In a statement, UNICEF reported a 46 percent increase in the number of children receiving treatment for SAM across Sudan's five Darfur states between January and May 2025, compared to the same period in 2024. "In North Darfur alone, more than 40,000 children were admitted for treatment for SAM in the first five months of the year -- double the number for the same period last year," according to the statement. "In nine out of 13 localities, the rate of acute malnutrition has surpassed emergency levels set by the World Health Organization," it noted. "Children in Darfur are being starved by conflict and cut off from the very aid that could save them," Sheldon Yett, UNICEF representative for Sudan, was quoted in the statement as saying. According to UNICEF, the situation was equally alarming in other parts of the country as SAM admissions rose by more than 70 percent in North Kordofan, by 174 percent in Khartoum State, and by 683 percent in Gezira State. UNICEF warned that, with Sudan now in the peak of the lean season, the risk of mass child mortality is growing rapidly in areas already near famine thresholds, adding that cholera outbreaks, measles cases, and collapsing health services are compounding the crisis. Sudan remains gripped by a civil conflict, which erupted in April 2023. The fighting has killed tens of thousands of people and displaced millions, both internally and across borders, deepening the country's humanitarian crisis.
